← Open Payments lookup

YVONNE FERMIL: Open Payments

NPI 1518086388 · SAN DIEGO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$749 in 34 payments from 12 companies in 2025. Trend: 2023 $0 · 2024 $387 · 2025 $749

Food & beverage: $749
CompanyPaymentsAmount
ABBVIE INC.9$156
Intercept Pharmaceuticals, Inc.4$94
Takeda Pharmaceuticals U.S.A., Inc.3$83
Salix Pharmaceuticals, a division of Bausch Health US, LLC4$74
PFIZER INC.3$72
GENZYME CORPORATION2$71
Braintree Laboratories, Inc.3$68
Novo Nordisk Inc2$38
Madrigal Pharmaceuticals1$30
Regeneron Healthcare Solutions, Inc.1$29

Products named: RINVOQ, DUPIXENT, OCALIVA, XIFAXAN, VELSIPITY, ENTYVIO, SUFLAVE, Wegovy.

Industry payments across CA — which companies pay providers there.